Scandinavian Biopharma has successfully completed the enrolment of the clinical Phase 1 trial in Zambia
We are proud to announce that, despite all challenges associated with the Covid-19 pandemic, all participants have now received the third and final vaccination dose in our Phase 1 trial in Zambia. The study started in 2019 and is part of the late phase development program in Africa for Scandinavian Biopharma’s vaccine candidate, ETVAX®, against […]
